Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Lasers in Medical Science
Erschienen in:

24.11.2020 | Brief Report

Treatment of lichen amyloidosis with fractional CO2 laser and topical steroid: a preliminary study of 10 cases

verfasst von: Meiling Wang, Yan Lin, Weizhi Wu, Yongmei Yu, Xiaodong Liu, Xiaoyuan Gao, Huaxu Liu

Erschienen in: Lasers in Medical Science | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Auszug

The primary localized cutaneous amyloidosis (PLCA) is characterized by the extracellular deposition of amyloid proteins in previously normal skin without systematic involvement [1]. The main subtypes of PLCA have been identified, which comprises lichen amyloidosis (LA), macular amyloidosis (MA), and nodular amyloidosis (NA). Additionally, the combined appearance of different subtypes will occur [2, 3]. Lichen amyloidosis (LA), the most common form of PLCA, presents with localized or rarely generalized, hyperpigmented macules or papules, which is usually located on the shins, calves, dorsal feet, forearms, or thighs [4, 5] with severe pruritus. And LA is reported to commonly present with MA lesions. Etiopathology and causal factors of LA have not been fully elucidated. And LA is considered to be related to heredity, long-term friction stimulation, EB virus infection, environment, and other factors [6]. …
Literatur
1.
Mehrotra K, Dewan R, Kumar JV, Dewan A (2017) Primary cutaneous amyloidosis: a clinical, histopathological and immunofluorescence study. J Clin Diagn Res 11(8):WC01–WC05PubMedPubMedCentral
2.
Cai D, Li Y, Zhou C, Jiang Y, Jiao J, Wu L (2017) Comparative proteomics analysis of primary cutaneous amyloidosis. Exp Ther Med 14(4):3004–3012CrossRef
3.
Cornejo KM, Lagana FJ, Deng A (2015) Nodular amyloidosis derived from keratinocytes: an unusual type of primary localized cutaneous nodular amyloidosis. Am J Dermatopathol 37(11):e129–e133CrossRef
4.
Chu H, Shin JU, Lee J, Park CO, Lee KH (2017) Successful treatment of lichen amyloidosis accompanied by atopic dermatitis by fractional CO2 laser. J Cosmet Laser Ther 19(6):345–346CrossRef
5.
Korbi M, Akkari H, Soua Y, Mohamed M, Youssef M, Belhajdali H, Zili J (2019) Lichen amyloidosis successfully treated with fractional ablative laser CO2: a new alternative therapeutic. J Cosmet Laser Ther 21(1):1–3CrossRef
6.
Esmat SM, Fawzi MM, Gawdat HI, Ali HS, Sayed SS (2015) Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis: a randomized clinical trial. Lasers Surg Med 47(5):388–395CrossRef
7.
Fang S, Shen X, Chen AJ, Li S, Shan K (2015) Health-related quality of life in patients with primary cutaneous amyloidosis. PLoS One 10(3):e0120623CrossRef
8.
Norisugi O, Yamakoshi T, Shimizu T (2014) Successful treatment of lichen amyloidosis using a CO2 surgical laser. Dermatol Ther 27(2):71–73CrossRef
9.
Yew YW, Tey HL (2014) Itch in familial lichen amyloidosis: effective treatment with amitriptyline in two cases. Dermatol Ther 27(1):12–15CrossRef
10.
Jin AG, Por A, Wee LK, Kai CK, Leok GC (2001) Comparative study of phototherapy (UVB) vs. photochemotherapy (PUVA) vs. topical steroids in the treatment of primary cutaneous lichen amyloidosis. Photodermatol Photoimmunol Photomed 17(1):42–43CrossRef
11.
Al Yahya RS (2016) Treatment of primary cutaneous amyloidosis with laser: a review of the literature. Lasers Med Sci 31(5):1027–1035CrossRef
12.
Sakuma TH, Hans-Filho G, Arita K, McGrath JA (2009) Familial primary localized cutaneous amyloidosis in Brazil. Arch Dermatol 145(6):695–699CrossRef
13.
Saki N, Ahramiyanpour N, Heiran A, Parvizi M (2020) Efficacy of topical dimethyl sulfoxide (DMSO) 50% solution vs tretinoin 0.5% cream in treatment of patients with primary macular amyloidosis: a split-side single-blinded randomized clinical trial. Dermatol Ther 33(3):e13305CrossRef
14.
Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA (2009) New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol 161(6):1217–1224CrossRef
15.
Merlini G, Seldin DC, Gertz MA (2011) Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 29(14):1924–1933CrossRef
16.
Apaydin R, Gurbuz Y, Bayramgurler D, Muezzinoglu B, Bilen N (2004) Cytokeratin expression in lichen amyloidosus and macular amyloidosis. J Eur Acad Dermatol Venereol 18(3):305–309CrossRef
17.
Sibaud V, Nougarolis S, Borjesson C, Gangloff D, Delord JP, Pompa V, Saintenac D, Roche H (2016) T-DM1 extravasation: first description. J Eur Acad Dermatol Venereol 30(7):1235–1236CrossRef
18.
Weidner T, Illing T, Elsner P (2017) Primary localized cutaneous amyloidosis: a systematic treatment review. Am J Clin Dermatol 18(5):629–642CrossRef
19.
Anitha B, Mysore V, Lichen Amyloidosis (2012) Novel treatment with fractional ablative 2,940 nm erbium: YAG laser treatment. J Cutan Aesthet Surg 5(2):141–143CrossRef
20.
Sobhi RM, Sharaoui I, El Nabarawy EA, El Nemr Esmail RS, Hegazy RA, Aref DHF (2018) Comparative study of fractional CO2 laser and fractional CO2 laser-assisted drug delivery of topical steroid and topical vitamin C in macular amyloidosis. Lasers Med Sci 33(4):909–916CrossRef
21.
Panchaprateep R, Tusgate S, Munavalli GS, Noppakun N (2015) Fractional 1,550 nm Ytterbium/Erbium fiber laser in the treatment of lichen amyloidosis: clinical and histological study. Lasers Surg Med 47(3):222–230CrossRef
22.
Nilforoushzadeh MA, Zolghadr S, Heidari-Kharaji M, Alavi S, Mahmoudbeyk M (2020) A comparative study of the efficacy of fractional neodymium-doped yttrium aluminum garnet (Nd: YAG) laser therapy alone and in combination with erbium: YAG laser therapy: tracing and objective measurement of melanin index in macular amyloidosis. Lasers Med Sci 35(5):1171–1177CrossRef
Metadaten
Titel
Treatment of lichen amyloidosis with fractional CO2 laser and topical steroid: a preliminary study of 10 cases
verfasst von
Meiling Wang
Yan Lin
Weizhi Wu
Yongmei Yu
Xiaodong Liu
Xiaoyuan Gao
Huaxu Liu
Publikationsdatum
24.11.2020
Verlag
Springer London
Erschienen in
Lasers in Medical Science / Ausgabe 5/2021
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-020-03188-8

Weitere Artikel der Ausgabe 5/2021

Effect of 940 nm laser diode irradiation prior to bonding procedure on postoperative sensitivity following class II composite restorations: a split-mouth randomized clinical trial

  • Original Article

Photosensitizer delivery by fibrin glue: potential for bypassing the blood-brain barrier

  • Original Article

Evaluation of photobiomodulation therapy to accelerate bone formation in the mid palatal suture after rapid palatal expansion: a randomized clinical trial

  • Original Article

Multimodal imaging with integrated auto-fluorescence and optical coherence tomography for identification of neck tissues

  • Original Article

Effect of using diode laser on Enterococcus faecalis and its lipoteichoic acid (LTA) in chronic apical periodontitis

  • Original Article

Z-scan method to measure the nonlinear optical behavior of cells for evaluating the cytotoxic effects of chemotherapy and hyperthermia treatments

  • Original Article